Hopp til hovedinnhold

Guillain-Barrè Syndrom

Sist oppdatert: Sist revidert:
Sist revidert av:
  1. Willison HJ, Jacobs BC, van Doorn PA.. Guillain-Barré syndrome. Lancet. 2016 Aug 13;388(10045):717-27. pmid:26948435 PubMed  
  2. Leonhard SE, Mandarakas MR, Gondim FAA, Bateman K, Ferreira MLB, Cornblath DR, van Doorn PA, Dourado ME, Hughes RAC, Islam B, Kusunoki S, Pardo CA, Reisin R, Sejvar JJ, Shahrizaila N, Soares C, Umapathi T, Wang Y, Yiu EM, Willison HJ, Jacobs BC. Diagnosis and management of Guillain-Barré syndrome in ten steps. Nat Rev Neurol. 2019 Nov;15(11):671-683. PMID: 31541214 PubMed  
  3. Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome. Lancet. 2021 Mar 27;397(10280):1214-1228. doi: 10.1016/S0140-6736(21)00517-1. Epub 2021 Feb 26. PMID: 33647239. PubMed  
  4. Verboon C1, van Berghem H1, van Doorn PA1, Ruts L2, Jacobs BC1,3.. Prediction of disease progression in Miller Fisher and overlap syndromes. J Peripher Nerv Syst. 2017; Dec;22(4): 446-450. pmid: 29065229 PubMed  
  5. Kim JK, Kim BJ, Shin HY, Shin KJ, Nam TS, Oh J, Suh BC, Yoon BA, Park HT, Huh SY, Oh SI, Bae JS. Acute bulbar palsy as a variant of Guillain-Barré syndrome.. Neurology 2016; Feb 23;86(8):: 742-7. pmid: 26718574 PubMed  
  6. Yuki N, Chan AC, Wong AHY, Inoue T, Yokai M, Kurihara T, Devaux JJ, Wilder-Smith E. Acute painful autoimmune neuropathy: A variant of Guillain-Barré syndrome. Muscle Nerve. 2017. pmid:28667708 PubMed  
  7. Marzoughi S, Marulanda L, Ngo D, Chen T. Pearls & Oy-sters: Delayed Diagnosis of Acute Motor Axonal Neuropathy With Cardiac Arrest. Neurology. 2022 Feb 22;98(8):336-339. PMID: 34906977. PubMed  
  8. Kuwabara S, Yuki N. Axonal Guillain-Barré syndrome: concepts and controversies. Lancet Neurol 2013; 12: 1180-8. pmid:24229616 PubMed  
  9. Shahrizaila N1, Kokubun N1, Sawai S1, Umapathi T1, Chan YC1, Kuwabara S1, Hirata K1, Yuki N2.. Antibodies to single glycolipids and glycolipid complexes in Guillain-Barré syndrome subtypes. Neurology. 2014; Jul 8;83(2):118-24: 118-24. pmid: 24920848 PubMed  
  10. Choi KD, Choi SY, Choi JH, Kim SH, Lee SH, Jeong SH, Kim HJ, Choi JY, Kim JS.. Characteristics of single ocular motor nerve palsy associated with anti-GQ1b antibody.. J Neurol. 2019; Feb;266(2: 476-479. pmid:30556099 PubMed  
  11. Hiew FL, Rajabally YA. Malignancy in Guillain-Barré syndrome: A twelve-year single-center study. J Neurol Sci. 2017 Apr 15;375:275-278. PMID: 28320147 PubMed  
  12. Gao Z, Li X, Peng T, Hu Z, Liu J, Zhen J, Gao Y. Systemic lupus erythematosus with Guillian-Barre syndrome: A case report and literature review. Medicine (Baltimore). 2018 Jun;97(25):e11160. PMID: 29924024 PubMed  
  13. Bourque PR, Brooks J, Warman-Chardon J, Breiner A. Cerebrospinal fluid total protein in Guillain-Barré syndrome variants: correlations with clinical category, severity, and electrophysiology. J Neurol. 2020 Mar;267(3):746-751. PMID: 31734909. PubMed  
  14. Fehmi J1, Scherer SS2, Willison HJ3, Rinaldi S4.. Nodes, paranodes and neuropathies. J Neurol Neurosurg Psychiatry. 2017. pmid:28819062 PubMed  
  15. Rajabally YA1, Hiew FL2, Winer JB2.. Influence of timing on electrodiagnosis of Guillain-Barré syndrome in the first six weeks: A retrospective study.. J Neurol Sci. 2015; Oct 15;357(1-2):143-5: 143-5. pmid:26194045 PubMed  
  16. Garg N1, Yuki N1, Park SB1, Barnett MH1, Kiernan MC1.. Acute bulbar, neck and limb weakness with monospecific anti-GT1a antibody: A rare localized subtype of Guillain-Barré sydnrome. Muscle Nerve. 2016; Jan;53(1):: 143-6.. pmid:26452439 PubMed  
  17. Yamagishi Y, Kuwahara M, Suzuki H, Sonoo M, Kuwabara S, Yokota T, Nomura K, Chiba A, Kaji R, Kanda T, Kaida KI, Mutoh T, Yamasaki R, Takashima H, Matsui M, Nishiyama K, Sobue G, Kusunoki S. Serum IgG anti-GD1a antibody and mEGOS predict outcome in Guillain-Barré syndrome. J Neurol Neurosurg Psychiatry. 2020 Oct 11:jnnp-2020-323960. PMID: 33041261. PubMed  
  18. Zhao N, Chang SH, Zhang QX, Zhang LJ, Jiang SM, Zhai H, Yang L. Clinical features of Guillain-Barré syndrome with anti-neurofascin 155 antibody. Acta Neurol Scand. 2022 Nov;146(5):553-561. doi: 10.1111/ane.13678. Epub 2022 Aug 4. PMID: 36237129. PubMed  
  19. Fehmi J, Davies AJ, Walters J, Lavin T, Keh R, Rossor AM, Munteanu T, Delanty N, Roberts R, Bäumer D, Lennox G, Rinaldi S. IgG1 pan-neurofascin antibodies identify a severe yet treatable neuropathy with a high mortality. J Neurol Neurosurg Psychiatry. 2021 Aug 16:jnnp-2021-326343. doi: 10.1136/jnnp-2021-326343. Epub ahead of print. PMID: 34400540. PubMed  
  20. Fels M, Fisse AL, Schwake C, Motte J, Athanasopoulos D, Grüter T, Spenner M, Breuer T, Starz K, Heinrich D, Grond M, Keyvani K, Appeltshauser L, Doppler K, Sommer C, Ayzenberg I, Schneider-Gold C, Gold R, Pitarokoili K, Labedi A. Report of a fulminant anti-pan-neurofascin-associated neuropathy responsive to rituximab and bortezomib. J Peripher Nerv Syst. 2021 Sep 5. doi: 10.1111/jns.12465. Epub ahead of print. PMID: 34486194. PubMed  
  21. Hughes RA, Swan AV, van Doorn PA. Intravenous immunoglobulin for Guillain-Barré syndrome. Cochrane Database Syst Rev 2014. pmid:25238327 PubMed  
  22. Hughes RA, Brassington R, Gunn AA, van Doorn PA. Corticosteroids for Guillain-Barré syndrome. Cochrane Database Syst Rev. 2016 Oct 24;10:CD001446 . pmid:27775812 PubMed  
  23. Verboon C, Harbo T, Cornblath DR, Hughes RAC, van Doorn PA, Lunn MP, Gorson KC, Barroso F, Kuwabara S, Galassi G, Lehmann HC, Kusunoki S, Reisin RC, Binda D, Cavaletti G, Jacobs BC; IGOS consortium; GOS consortium. Intravenous immunoglobulin treatment for mild Guillain-Barré syndrome: an international observational study. J Neurol Neurosurg Psychiatry. 2021 Jun 8:jnnp-2020-325815. doi: 10.1136/jnnp-2020-325815. Epub ahead of print. PMID: 34103340. PubMed  
  24. Goedee HS, Rajabally YA. To treat or not to treat mild Guillain-Barré syndrome: limited evidence for but still none against. J Neurol Neurosurg Psychiatry. 2021 Jun 8:jnnp-2021-326848. doi: 10.1136/jnnp-2021-326848. Epub ahead of print. PMID: 34103337.
  25. Verboon C, Doets AY, Galassi G, Davidson A, Waheed W, Péréon Y, Shahrizaila N, Kusunoki S, Lehmann HC, Harbo T, Monges S, Van den Bergh P, Willison HJ, Cornblath DR, Jacobs BC; IGOS Consortium.. Current treatment practice of Guillain-Barré syndrome.. Neurology. 2019. pmid:31175208 PubMed  
  26. Kalita J, Misra UK, Chaudhary SK, Das M, Mishra A, Ranjan A, Kumar M. Outcome of Guillain-Barré syndrome following intravenous immunoglobulin compared to natural course. Eur J Neurol. 2022 Oct;29(10):3071-3080. doi: 10.1111/ene.15500. Epub 2022 Aug 2. PMID: 35837807. PubMed  
  27. Winer JB. When the Guillain-Barre patient fails to respond to treatment. Pract Neurol 2009; 9: 227-30. PMID: 19608773 PubMed  
  28. Walgaard C, Lingsma HF, van Doorn PA, van der Jagt M, Steyerberg EW, Jacobs BC. Tracheostomy or Not: Prediction of Prolonged Mechanical Ventilation in Guillain-Barré Syndrome. Neurocrit Care. 2017 Feb;26(1):6-13. doi: 10.1007/s12028-016-0311-5. PMID: 27538676; PMCID: PMC5227005.
  29. Verboon C, van den Berg B, Cornblath DR, Venema E, Gorson KC, Lunn MP, Lingsma H, Van den Bergh P, Harbo T, Bateman K, Pereon Y, Sindrup SH, Kusunoki S, Miller J, Islam Z, Hartung HP, Chavada G, Jacobs BC, Hughes RAC, van Doorn PA; IGOS Consortium. Original research: Second IVIg course in Guillain-Barré syndrome with poor prognosis: the non-randomised ISID study. J Neurol Neurosurg Psychiatry. 2020 Feb;91(2):113-121. PMID: 31586949. PubMed  
  30. Oczko-Walker M, Manousakis G, Wang S, Malter JS, Waclawik AJ. Plasma exchange after initial intravenous immunoglobulin treatment in Guillain-Barré syndrome: critical reassessment of effectiveness and cost-efficiency. J Clin Neuromuscul Dis. 2010 Dec;12(2):55-61 . pmid:21386771 PubMed  
  31. Verboon C, van Doorn PA, Jacobs BC.Treatment dilemmas in Guillain-Barré syndrome.. J Neurol Neurosurg Psychiatry. 2017. pmid: 27837102 PubMed  
  32. Rajabally YA, Uncini A.. Outcome and its predictors in Guillain-Barre syndrome. J Neurol Neurosurg Psychiatry ; 83(7): 711-8. pmid:22566597 PubMed  
  33. van den Berg B, Storm EF, Garssen MJP, Blomkwist-Markens PH, Jacobs BC. Clinical outcome of Guillain-Barré syndrome after prolonged mechanical ventilation. J Neurol Neurosurg Psychiatry. 2018 Sep;89(9):949-954. PMID: 29627773 PubMed  
  34. van den Berg B, Bunschoten C, van Doorn PA, Jacobs BC. Mortality in Guillain-Barre syndrome. Neurology. 2013 Apr 30;80(18):1650-4. doi: 10.1212/WNL.0b013e3182904fcc. Epub 2013 Apr 10. PMID: 23576619. PubMed  
  35. Wakerley BR, Wilder-Smith EP, Yuki N. Stumbling towards a diagnosis. Pract Neurol 2015; 15: 236-9. pmid:25918431 PubMed  
  36. Durcan R, Murphy O, Reid V, Lynch T. Guillain-Barré syndrome mimicking botulism in early disease course. Pract Neurol. 2018 Jul 30. pii: practneurol-2018-001891. PMID: 30061335 PubMed  
  • Unn Ljøstad, spesialist i nevrologi, professor PhD
  • Åse Mygland, spesialist i nevrologi, professor dr med
  • Christian Vedeler, spesialist i nevrologi, professor dr med